Annual EBIT
-$206.06 M
-$59.16 M-40.27%
31 December 2023
Summary:
Day One Biopharmaceuticals annual earnings before interest & taxes is currently -$206.06 million, with the most recent change of -$59.16 million (-40.27%) on 31 December 2023. During the last 3 years, it has fallen by -$192.28 million (-1395.17%). DAWN annual EBIT is now -1395.17% below its all-time high of -$13.63 million.DAWN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$29.64 M
+$144.44 M+125.81%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly earnings before interest & taxes is currently $29.64 million, with the most recent change of +$144.44 million (+125.81%) on 30 September 2024. Over the past year, it has increased by +$81.07 million (+157.61%). DAWN quarterly EBIT is now -61.26% below its all-time high of $76.51 million, reached on 01 March 2019.DAWN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$211.46 M
+$81.07 M+27.71%
30 September 2024
Summary:
Day One Biopharmaceuticals TTM earnings before interest & taxes is currently -$211.46 million, with the most recent change of +$81.07 million (+27.71%) on 30 September 2024. Over the past year, it has dropped by -$22.16 million (-11.71%). DAWN TTM EBIT is now -245.29% below its all-time high of $145.54 million, reached on 01 September 2019.DAWN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.3% | +157.6% | -11.7% |
| 3 y3 years | -1395.2% | +254.1% | -275.4% |
| 5 y5 years | - | +102.0% | -246.7% |
DAWN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1395.2% | at low | at high | +125.8% | -275.4% | +27.7% |
| 5 y | 5 years | -1395.2% | at low | -48.8% | +125.8% | -245.3% | +27.7% |
| alltime | all time | -1395.2% | at low | -61.3% | +125.8% | -245.3% | +27.7% |
Day One Biopharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $29.64 M(-125.8%) | -$211.46 M(-27.7%) |
| June 2024 | - | -$114.81 M(+72.0%) | -$292.53 M(+28.9%) |
| Mar 2024 | - | -$66.77 M(+12.2%) | -$226.98 M(+10.1%) |
| Dec 2023 | -$206.06 M(+40.3%) | -$59.52 M(+15.7%) | -$206.06 M(+8.9%) |
| Sept 2023 | - | -$51.44 M(+4.4%) | -$189.29 M(+6.6%) |
| June 2023 | - | -$49.25 M(+7.4%) | -$177.55 M(+7.6%) |
| Mar 2023 | - | -$45.85 M(+7.3%) | -$165.02 M(+12.3%) |
| Dec 2022 | -$146.91 M(+102.0%) | -$42.74 M(+7.7%) | -$146.91 M(+16.5%) |
| Sept 2022 | - | -$39.70 M(+8.1%) | -$126.11 M(+19.4%) |
| June 2022 | - | -$36.72 M(+32.3%) | -$105.65 M(+25.2%) |
| Mar 2022 | - | -$27.75 M(+26.4%) | -$84.37 M(+16.0%) |
| Dec 2021 | -$72.74 M | -$21.95 M(+14.1%) | -$72.70 M(+29.1%) |
| Sept 2021 | - | -$19.23 M(+24.6%) | -$56.32 M(+37.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$15.44 M(-4.0%) | -$40.92 M(+46.8%) |
| Mar 2021 | - | -$16.09 M(+189.3%) | -$27.88 M(+102.3%) |
| Dec 2020 | -$13.78 M(-7.5%) | -$5.56 M(+45.1%) | -$13.78 M(-313.8%) |
| Sept 2020 | - | -$3.83 M(+59.8%) | $6.45 M(-90.5%) |
| June 2020 | - | -$2.40 M(+20.6%) | $68.10 M(+3.7%) |
| Mar 2020 | - | -$1.99 M(-113.6%) | $65.66 M(-54.5%) |
| Dec 2019 | -$14.91 M | - | - |
| Dec 2019 | - | $14.67 M(-74.6%) | $144.16 M(-1.0%) |
| Sept 2019 | - | $57.82 M(-1294.6%) | $145.54 M(+12.2%) |
| June 2019 | - | -$4.84 M(-106.3%) | $129.77 M(-7.4%) |
| Mar 2019 | - | $76.51 M(+376.5%) | $140.17 M(+120.2%) |
| Dec 2018 | - | $16.05 M(-61.8%) | $63.66 M(+33.7%) |
| Sept 2018 | - | $42.05 M(+656.8%) | $47.61 M(+756.8%) |
| June 2018 | - | $5.56 M | $5.56 M |
FAQ
- What is Day One Biopharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual EBIT year-on-year change?
- What is Day One Biopharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly EBIT year-on-year change?
- What is Day One Biopharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals TTM EBIT year-on-year change?
What is Day One Biopharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of DAWN is -$206.06 M
What is the all time high annual EBIT for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual earnings before interest & taxes is -$13.63 M
What is Day One Biopharmaceuticals annual EBIT year-on-year change?
Over the past year, DAWN annual earnings before interest & taxes has changed by -$59.16 M (-40.27%)
What is Day One Biopharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of DAWN is $29.64 M
What is the all time high quarterly EBIT for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly earnings before interest & taxes is $76.51 M
What is Day One Biopharmaceuticals quarterly EBIT year-on-year change?
Over the past year, DAWN quarterly earnings before interest & taxes has changed by +$81.07 M (+157.61%)
What is Day One Biopharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of DAWN is -$211.46 M
What is the all time high TTM EBIT for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high TTM earnings before interest & taxes is $145.54 M
What is Day One Biopharmaceuticals TTM EBIT year-on-year change?
Over the past year, DAWN TTM earnings before interest & taxes has changed by -$22.16 M (-11.71%)